LGALS9 and carcinoma: Upon quantification of adherent cells using MTS, a clear dose-dependent decrease in cell adhesion was detected for the Gal-9-sensitive FaDu (Figure 5A), Gal-9-resistant WiDr (Figure 5B), and a panel of different carcinoma cell lines with the exception of Caco2 (Figure 5C).